MPO and enteritis: On day 10, oral administration of Ancientino (300, 600, and 1200 mg/kg) protected (p < 0.05) against body weight loss (1.15-, 1.23-, and 1.32-fold, Figure 1A), decreased the DAI score (20.6%, 44.4% and 50.8%, Figure 1B), prevented colon shortening (1.29-, 1.40-, and 1.50-fold, Figure 1C), decreased MPO activity (21.3%, 35.6%, and 44.0%, Figure 1D), and improved the pathological inflammation and crypt damage (16.7%, 40.5%, and 66.7%, Figure 1E,F) compared with that in the DSS-induced enteritis mice group, respectively.